Genomic analysis of nontypeable pneumococci causing invasive pneumococcal disease in South Africa, 2003-2013

Thabo Mohale1,2, Nicole Wolter3,4, Mushal Allam3

  • 1Centre for Respiratory Diseases and Meningitis (CRDM), National Institute for Communicable Diseases (NICD), National Health Laboratory Services (NHLS), Johannesburg, South Africa. thabom@nicd.ac.za.

BMC Genomics
|June 24, 2016
PubMed
Abstract

Insights

Nontypeable pneumococci (NTPn) are rare but genetically diverse causes of invasive pneumococcal disease. This study characterized NTPn in South Africa, finding mutations and higher antibiotic resistance, highlighting their potential public health impact.

Area of Science:

  • Microbiology
  • Genomics
  • Epidemiology

Background:

  • Streptococcus pneumoniae's capsular polysaccharide is key for virulence and vaccine targets.
  • Nontypeable pneumococci (NTPn) are poorly understood pathogens.
  • This study aimed to characterize NTPn causing invasive pneumococcal disease in South Africa.

Observation:

  • NTPn isolates were identified through national surveillance in South Africa from 2003-2013.
  • Whole genome analysis was used to characterize isolates, predict ancestral serotypes, and identify antimicrobial resistance.
  • 39 NTPn cases were reported, with 56% having partial capsular genes and 44% complete deletion.

Findings:

  • Ancestral serotypes 1 and 8 were most prevalent among NTPn.
  • Over half of ancestral serotypes were included in the 13-valent pneumococcal conjugate vaccine.
  • Mutations in the capsular region were identified, potentially causing the nontypeable phenotype, and higher resistance to tetracycline and erythromycin was observed.

Implications:

  • NTPn represent a genetically diverse group of pathogens.
  • Understanding NTPn is crucial for developing effective vaccines and treatments.
  • The findings highlight the need for continued surveillance and characterization of these evolving pathogens.